RBL001/RBL002 / BioNTech  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
RBL001/RBL002 / BioNTech
MERIT, NCT01684241: RBL001/RBL002 Phase I Clinical Trial

Completed
1
29
Europe
RBL001/RBL002, cancer vaccine
BioNTech RNA Pharmaceuticals GmbH
Melanoma
05/15
07/15
NCT02035956: IVAC MUTANOME Phase I Clinical Trial

Completed
1
15
Europe
IVAC MUTANOME, RBL001/RBL002, cancer vaccine
BioNTech RNA Pharmaceuticals GmbH
Melanoma
02/17
10/19

Download Options